Probuphine is a Subcutaneous Implant in the Human Prescription Drug category. It is labeled and distributed by Titan Pharmaceuticals, Inc.. The primary component is Buprenorphine Hydrochloride.
| Product ID | 52440-100_059a263d-9a75-4c1e-a0c6-73867047e0c8 |
| NDC | 52440-100 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Probuphine |
| Generic Name | Buprenorphine Hydrochloride |
| Dosage Form | Implant |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2016-06-09 |
| Marketing Category | NDA / NDA |
| Application Number | NDA204442 |
| Labeler Name | Titan Pharmaceuticals, Inc. |
| Substance Name | BUPRENORPHINE HYDROCHLORIDE |
| Active Ingredient Strength | 80 mg/1 |
| Pharm Classes | Partial Opioid Agonists [MoA],Partial Opioid Agonist [EPC] |
| DEA Schedule | CIII |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2016-06-09 |
| Marketing End Date | 2021-08-31 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA204442 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2016-06-09 |
| Ingredient | Strength |
|---|---|
| BUPRENORPHINE HYDROCHLORIDE | 80 mg/1 |
| SPL SET ID: | f635d975-6bb4-4233-953b-d5724e993839 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 52440-100 | Probuphine | buprenorphine hydrochloride |
| 58284-100 | Probuphine | Probuphine |
| 55700-867 | BELBUCA | buprenorphine hydrochloride |
| 12496-0757 | Buprenex | buprenorphine hydrochloride |
| 50090-2924 | Buprenorphine | Buprenorphine Hydrochloride |
| 0143-9246 | Buprenorphine Hydrochloride | Buprenorphine Hydrochloride |
| 0409-2012 | Buprenorphine Hydrochloride | Buprenorphine Hydrochloride |
| 0517-0725 | Buprenorphine Hydrochloride | Buprenorphine Hydrochloride |
| 21695-515 | Buprenorphine Hydrochloride | Buprenorphine Hydrochloride |
| 35356-556 | buprenorphine hydrochloride | buprenorphine hydrochloride |
| 42023-179 | Buprenorphine Hydrochloride | Buprenorphine Hydrochloride |
| 50090-1571 | buprenorphine hydrochloride | buprenorphine hydrochloride |
| 50383-924 | buprenorphine hydrochloride | buprenorphine hydrochloride |
| 50383-930 | buprenorphine hydrochloride | buprenorphine hydrochloride |
| 53217-246 | buprenorphine hydrochloride | buprenorphine hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() PROBUPHINE 86356901 5171923 Live/Registered |
Titan Pharmaceuticals, Inc. 2014-08-04 |
![]() PROBUPHINE 85867659 5166633 Live/Registered |
Titan Pharmaceuticals, Inc. 2013-03-05 |
![]() PROBUPHINE 85110551 4102980 Live/Registered |
Titan Pharmaceuticals, Inc. 2010-08-18 |
![]() PROBUPHINE 76281064 2800862 Dead/Cancelled |
Titan Pharmaceuticals, Inc. 2001-07-06 |